癌症研究档案

  • 国际标准期刊号: 2254-6081
  • 期刊 h 指数: 13
  • 期刊引用分数: 3.58
  • 期刊影响因子: 3.12
索引于
  • 中国知网(CNKI)
  • 引用因子
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

A scoping study of patient-reported outcomes in sarcoma

Peter Mazzone

Sarcoma could be a heterogeneous cluster of tumours, typically poignant young patients and associated with each endogenous and exogenous risk factor. The importance of getting the patient's perspective of the unwellness expertise is imperative. Patient-reported outcomes (PROs) square measure the outcomes that return directly from the patient. They embrace symptoms, useful health, well-being, quality of life, psychological problems, among different indicators according by the patients. The target of this scoping review was to map the execs in malignant neoplastic disease patients and the way they're measured. Epigenetic mechanisms of tumorigenesis are concerned in mesenchymal tumors starting from chondroblastoma and large cell tumour of bone to sarcoma, malignant peripheral nerve sheath tumor, secretion malignant neoplastic disease, and epithelioid malignant neoplastic disease and Ewing malignant neoplastic disease - all diseases that gift in an exceedingly younger patient population than most cancers. Finally, we have a tendency to review current and potential future approaches for the event of malignant neoplastic disease therapies supported this rising understanding of body substance deregulation.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证